ACA Stock Recent News

Arcosa (ACA) is well positioned to outperform the market, as it exhibits above-average growth in financials.

The mean of analysts' price targets for Arcosa (ACA) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that its Board of Directors has declared a regular quarterly cash dividend of $0.05 per share on its $0.01 par value common stock. The quarterly cash dividend is payable July 31, 2025 to stockholders of record as of July 15, 2025. About Arcosa Arcosa, Inc. (NYSE:ACA), headquartered in Dallas, Texas, is a provider of infrastructure-related pr.

Arcosa, Inc. (NYSE:ACA ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Erin Drabek - Director of Investor Relations Antonio Carrillo - President and Chief Executive Officer Gail Peck - Chief Financial Officer Conference Call Participants Julio Romero - Sidoti & Company. Brent Thielman - D.A.

Arcosa (ACA) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.73 per share a year ago.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa,” the “Company,” “We,” or “Our”), a provider of infrastructure-related products and solutions, today announced results for the first quarter ended March 31, 2025. First Quarter 2025 Highlights   Three Months Ended March 31,   2025   2024   % Change               ($ in millions, except per share amounts)     Revenues $ 632.0     $ 598.6     6 % Revenues, excluding the impact of divested business(1) $ 632.0     $ 562.5     12 % Net income.

ARCB, ACA and BAND have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2025.

The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.

DALLAS--(BUSINESS WIRE)--Arcosa, Inc. (NYSE: ACA) (“Arcosa” or the “Company”), a provider of infrastructure-related products and solutions, today announced that it will release results for the first quarter ended March 31, 2025 after markets close on Tuesday, May 6, 2025. The Company will host an earnings call to discuss the results at 8:30 a.m. Eastern Time on Wednesday, May 7, 2025. The call can be accessed as follows: Webcast and slide presentation: https://ir.arcosa.com   The slides will be.

AAL, ACA and BLKB have been added to the Zacks Rank #5 (Strong Sell) List on April 15, 2025.